Biodesix Inc 's Cash & cash equivalent grew by 17.3 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Biodesix Inc 's Quick Ratio to 1.96, above Biodesix Inc average Quick Ratio.

Within Medical Laboratories industry 17 other companies have achieved higher Quick Ratio than Biodesix Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 1524, from total ranking in the first quarter 2026 at 2346.

Explain Quick Ratio?
How much Cash & cash equivalents BDSX�s has?
What are BDSX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BDSX Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	0.86 %	8.81 %	21.79 %	40.03 %	-13.63 %
Y / Y Cash & cash equivalent Change	44.71 %	45.27 %	-27.65 %	-47.13 %	-50.9 %
Quick Ratio MRQ	1.96	1.76	1.09	0.91	1.37
BDSX's Total Ranking	# 1524	# 2346	# 2377	# 1987	# 2045
Seq. Current Liabilities Change	5.54 %	-16.9 %	-3.94 %	19.74 %	13.85 %
Seq. Cash & cash equivalent Change	17.3 %	34.68 %	14.35 %	-19.9 %	17.75 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 18
Healthcare Sector	# 507
Overall Market	# 1430

Quick Ratio Statistics
High	Average	Low
4.03	1.4	0.14
(Mar 31 2021)		(Sep 30 2020)

Financial Statements
Biodesix Inc 's Current Liabilities	$ 15 Millions	Visit BDSX's Balance sheet
Biodesix Inc 's Cash & cash equivalent	$ 30 Millions	Visit BDSX's Balance sheet
Source of BDSX's Sales		Visit BDSX's Sales by Geography

Cumulative Biodesix Inc 's Quick Ratio

BDSX's Quick Ratio for the trailling 12 Months

BDSX Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	17.24 %	12.19 %	-15.77 %	-35.96 %	-51.45 %
Y / Y Cash & cash equivalent TTM Growth	-5.02 %	-30.29 %	-33.62 %	-27.13 %	-3.86 %
Quick Ratio TTM	1.39	1.26	1.15	1.33	1.72
Total Ranking TTM	# 1093	# 1338	# 881	# 713	# 627
Seq. Current Liabilities TTM Growth	0.2 %	1.83 %	5.12 %	9.31 %	-4.11 %
Seq. Cash & cash equivalent TTM Growth	11.32 %	10.78 %	-8.94 %	-15.42 %	-18.29 %

Quick ratio ranking by company, industry and sector >> Back to BDSX Financial Strength Comparisons >> Go to Compare BDSX Quick Ratio to its Competitors

On the trailing twelve months basis BDSX Cash & cash equivalent soared by 44.71 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Biodesix Inc 's Quick Ratio to 1.39, above BDSX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 34 other companies have achieved higher Quick Ratio than Biodesix Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2853.

Explain Quick Ratio?
How much Cash & cash equivalents BDSX�s has?
What are BDSX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 35
Healthcare Sector	# 887
Within the Market	# 1524

trailing twelve months Quick Ratio Statistics
High	Average	Low
2.4	1.17	0.05
(Sep 30 2021)		(Sep 30 2020)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Castle Biosciences Inc	4.72	$ 266.805 Millions	$ 56.509 Millions
Bionexus Gene Lab Corp	4.33	$ 3.522 Millions	$ 0.813 Millions
Caredx Inc	3.99	$ 373.636 Millions	$ 93.698 Millions
Omniab Inc	3.78	$ 51.995 Millions	$ 13.758 Millions
Fulgent Genetics Inc	3.58	$ 257.032 Millions	$ 71.756 Millions
Guardant Health Inc	3.11	$ 1,053.469 Millions	$ 338.962 Millions
Butterfly Network Inc	2.13	$ 124.659 Millions	$ 58.603 Millions
Natera Inc	1.97	$ 1,091.502 Millions	$ 553.200 Millions
Biodesix Inc	1.96	$ 29.996 Millions	$ 15.291 Millions
Sera Prognostics Inc	1.91	$ 46.445 Millions	$ 24.356 Millions
Exagen Inc	1.83	$ 24.588 Millions	$ 13.457 Millions
Radnet Inc	1.11	$ 773.510 Millions	$ 697.822 Millions
Bioaffinity Technologies Inc	0.91	$ 2.430 Millions	$ 2.681 Millions
Ispecimen inc	0.43	$ 4.426 Millions	$ 10.196 Millions
Quest Diagnostics Inc	0.40	$ 720.000 Millions	$ 1,788.000 Millions

Date modified: 2026-09-10T09:11:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.